Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3547-3557
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3547
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3547
Figure 2 Proposed hierarchy of liver cancer stem cells according to the current literature.
Liver cancer stem cell markers have been defined that can give rise to ALDH+CD133+, EpCAM+CD90+, CD133+CD44+ and other early progenitor cells, each of which can subsequently divide into more differentiated progenitor cells. Rounded arrows show cells with self-renewal capacity that have the potential to serve as CSCs. Small arrows show the unproven potential for “de-differentiation”. CSCs: Cancer stem cells.
- Citation: Sun JH, Luo Q, Liu LL, Song GB. Liver cancer stem cell markers: Progression and therapeutic implications. World J Gastroenterol 2016; 22(13): 3547-3557
- URL: https://www.wjgnet.com/1007-9327/full/v22/i13/3547.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i13.3547